ACOT11 suppresses prostate cancer progression by inhibiting mitochondrial homeostasis and the PI3K/AKT signaling pathway
This study demonstrates that ACOT11 acts as a tumor suppressor in prostate cancer by inhibiting disease progression through the disruption of mitochondrial homeostasis and the suppression of the PI3K/AKT signaling pathway, suggesting its potential as a biomarker and therapeutic target for castration-resistant prostate cancer.